Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity

The neighbor-joining method: a new method for reconstructing phylogenetic trees.

Saitou, N., & Nei, M. (1987) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a040454 · Cited by 59,959

MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms

Kumar, S., Stecher, G., Li, M., Knyaz, C., & Tamura, K. (2018) · Molecular Biology and Evolution · doi:10.1093/molbev/msy096 · Cited by 37,683

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969

From local explanations to global understanding with explainable AI for trees

Lundberg, S. M., Erion, G., Chen, H., DeGrave, A., Prutkin, J. M., Nair, B., Katz, R., Himmelfarb, J., Bansal, N., & Lee, S.-I. (2020) · Nature Machine Intelligence · doi:10.1038/s42256-019-0138-9 · Cited by 10,551

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897

Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein

Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., Zhang, L., et al. (2020) · Nature · doi:10.1038/s41586-020-2180-5 · Cited by 5,983

Origin and evolution of pathogenic coronaviruses

Cui, J., Li, F., & Shi, Z. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0118-9 · Cited by 5,729

Prospects for inferring very large phylogenies by using the neighbor-joining method

Tamura, K., Nei, M., & Kumar, S. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404206101 · Cited by 5,588

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405

Contributing factors common to COVID‑19 and gastrointestinal cancer

Kostoff, R. N., Briggs, M. B., Kanduc, D., Shores, D. R., Kovatsi, L., Drakoulis, N., Porter, A. L., Tsatsakis, A. M., & Spandidos, D. A. (2021) · Oncology Reports · doi:10.3892/or.2021.8227 · Cited by 11

Sequence similarity of HSP65 of Mycobacterium bovis BCG with SARS-CoV-2 spike and nuclear proteins: may it predict an antigen-dependent immune protection of BCG against COVID-19?

Finotti, P. (2021) · Cell Stress and Chaperones · doi:10.1007/s12192-021-01244-y · Cited by 11

Assessment of Virological Contributions to COVID-19 Outcomes in a Longitudinal Cohort of Hospitalized Adults

Simons, L. M., Lorenzo-Redondo, R., Gibson, M., Kinch, S. L., Vandervaart, J. P., Reiser, N. L., Eren, M., Lux, E., McNally, E. M., Tambur, A. R., et al. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac027 · Cited by 11

Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape

Oliveira, J. R., Remuzgo, C., Machado, R. R. G., Magawa, J. Y., Daher, I. P., Urbanski, A. H., Schmitz, G. J. H., Arcuri, H. A., Ferreira, M. A., Sasahara, G. L., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1010105 · Cited by 11

Dynamics of infection-elicited SARS-CoV-2 antibodies in children over timePreprint

Gentles, L. E., Kehoe, L., Crawford, K. H. D., Lacombe, K., Dickerson, J. A., Wolf, C. R., Yuan, J., Schuler, S., Watson, J. T., Nyanseor, S., et al. (2022) · medRxiv · doi:10.1101/2022.01.14.22269235 · Cited by 11

Deep immunoglobulin repertoire sequencing depicts a comprehensive atlas of spike-specific antibody lineages shared among COVID-19 convalescents

Yan, Q., Zhang, Y., Hou, R., Pan, W., Liang, H., Gao, X., Deng, W., Huang, X., Qu, L., Tang, C., et al. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2290841 · Cited by 9

Titers of IgG and IgA against SARS-CoV-2 proteins and their association with symptoms in mild COVID-19 infection

Abril, A. G., Alejandre, J., Mariscal, A., Alserawan, L., Rabella, N., Román, E. M., López-Contreras, J., Navarro, F., Serrano, E., Nomdedeu, J. F., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-59634-y · Cited by 10

Comprehensive phage display viral antibody profiling using VirScan: potential applications in chronic immune-mediated disease

Shrewsbury, J. V., Vitus, E. S., Koziol, A., Nenarokova, A., Jess, T., & Elmahdi, R. (2024) · Journal of Virology · doi:10.1128/jvi.01102-24 · Cited by 13

Demographic and genetic factors shape the epitope specificity of the human antibody repertoire against viruses

Olin, A., Pou, C., Jaquaniello, A., Crook, J. M., Tan, Z., Roux, M., Dubois, F., Charbit, B., Liu, D., Donnadieu, F., et al. (2026) · Nature Immunology · doi:10.1038/s41590-026-02432-7 · Cited by 12

No substantial preexisting B cell immunity against SARS-CoV-2 in healthy adults

Ercanoglu, M. S., Gieselmann, L., Dähling, S., Poopalasingam, N., Detmer, S., Koch, M., Korenkov, M., Halwe, S., Klüver, M., Cristanziano, V. D., et al. (2022) · iScience · doi:10.1016/j.isci.2022.103951 · Cited by 9

Higher Antibody Concentrations in Health Care Workers Associated With Greater Reactogenicity Post-Vaccination

Dickerson, J. A., Englund, J. A., Wang, X., Brown, J. C. S., Zerr, D. M., Strelitz, B., & Klein, E. J. (2021) · Vaccines · doi:10.3390/vaccines10040601 · Cited by 10

Serological responses to human virome define clinical outcomes of Italian patients infected with SARS-CoV-2

Wang, L., Candia, J., Ma, L., Zhao, Y., Imberti, L., Sottini, A., Quirós-Roldán, E., Dobbs, K., Burbelo, P. D., Cohen, J. I., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.78002 · Cited by 10

Humoral Immune Response Profile of COVID-19 Reveals Severity and Variant-Specific Epitopes: Lessons from SARS-CoV-2 Peptide Microarray

Acharjee, A., Ray, A., Salkar, A., Bihani, S., Tuckley, C., Shastri, J. S., Agrawal, S. R., Duttagupta, S. P., & Srivastava, S. (2023) · Viruses · doi:10.3390/v15010248 · Cited by 10

Mapping human norovirus antigens during infection reveals the breadth of the humoral immune response

Su, L., Huang, W., Neill, F. H., Estes, M. K., Atmar, R. L., & Palzkill, T. G. (2023) · npj Vaccines · doi:10.1038/s41541-023-00683-1 · Cited by 10

Persistent immune and clotting dysfunction detected in saliva and blood plasma after COVID-19

Jang, H., Choudhury, S. N., Yu, Y., Sievers, B. L., Gelbart, T., Singh, H., Rawlings, S. A., Proal, A. D., Tan, G. S., Qian, Y., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17958 · Cited by 12

Unraveling the copper-death connection: Decoding COVID-19‘s immune landscape through advanced bioinformatics and machine learning approaches

Wang, Q., Su, Z., Zhang, J., Yan, H., & Zhang, J. (2024) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2024.2310359 · Cited by 10

Methods to Identify Immunogenic Peptides in SARS‐CoV‐2 Spike and Protective Monoclonal Antibodies in COVID‐19 Patients

Li, L., Gao, M., Li, J., Zu, S., Wang, Y., Chen, C., Wan, D., Duan, J., Aliyari, R., Wang, J., et al. (2021) · Small Methods · doi:10.1002/smtd.202100058 · Cited by 9

Longitudinal and proteome-wide analyses of antibodies in COVID-19 patients reveal features of the humoral immune response to SARS-CoV-2

Wang, J., Yang, Y., Liang, T., Yang, N., Li, T., Zheng, C. J., Ning, N., Luo, D., Yang, X., He, Z., et al. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.07.008 · Cited by 10

Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19–convalescent individuals

Min, L., Liu, J., Lu, R., Zhang, Y., Du, M., Xing, M., Wu, Z., Kong, X., Zhu, Y., Zhou, X., et al. (2022) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2022.01.005 · Cited by 10

Nonself Mutations in the Spike Protein Suggest an Increase in the Antigenicity and a Decrease in the Virulence of the Omicron Variant of SARS-CoV-2

Otaki, J. M., Nakasone, W., & Nakamura, M. (2022) · COVID · doi:10.3390/covid2030029 · Cited by 9

Cross-Recognition of SARS-CoV-2 B-Cell Epitopes with Other Betacoronavirus Nucleoproteins

Tajuelo, A., López‐Siles, M., Más, V., Pérez‐Romero, P., Aguado, J. M., Briz, V., McConnell, M. J., Martín-Galiano, A. J., & López, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23062977 · Cited by 10

High-resolution analysis of long-term serum antibodies in humans following convalescence of SARS-CoV-2 infection

Facciuolo, A., Scruten, E., Lipsit, S., Lang, A. L. S., Cates, Z. P., Lew, J. M., Falzarano, D., Gerdts, V., KUSALIK, A. J., & Napper, S. (2022) · Scientific Reports · doi:10.1038/s41598-022-12032-8 · Cited by 9

A high CMV-specific T cell response associates with SARS-CoV-2-specific IL-17 T cell production

Frozza, F. T. B., Fazolo, T., de Souza, P. O., Lima, K. R., da Fontoura, J. C., Borba, T. S., Polese-Bonatto, M., Kern, L. B., Stein, R. T., Pawelec, G., et al. (2022) · Medical Microbiology and Immunology · doi:10.1007/s00430-022-00758-1 · Cited by 11

Protective immunity induced by an inhaled SARS-CoV-2 subunit vaccine

Elder, E., Revanna, C. B., Johansson, C., Wallin, R. P. A., Sjödahl, J., Winqvist, O., & Mirazimi, A. (2023) · Vaccine · doi:10.1016/j.vaccine.2023.06.015 · Cited by 10

A Delay Differential Equation approach to model the COVID-19 pandemicPreprint

Kiselev, I. N., Akberdin, I. R., & Kolpakov, F. (2021) · medRxiv · doi:10.1101/2021.09.01.21263002 · Cited by 10

Recent common human coronavirus infection protects against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A Veterans Affairs cohort study

Fillmore, N. R., Szalat, R. E., La, J., Branch‐Elliman, W., Monach, P. A., Nguyen, V., Samur, M., Brophy, M. T., Do, N., & Munshi, N. C. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2213783119 · Cited by 10

Serodynamics: a review of methods for epidemiological inference using serological dataPreprint

Hay, J. A., Routledge, I., & Takahashi, S. (2023) · doi:10.31219/osf.io/kqdsn · Cited by 10

Improvement of mucosal immunity by a live-attenuated SARS-CoV-2 nasal vaccine

Yeung, J., Wang, T., & Shi, P. (2023) · Current Opinion in Virology · doi:10.1016/j.coviro.2023.101347 · Cited by 9

PhIP-Seq: methods, applications and challenges

Huang, Z., Gunarathne, S. M. S., Liu, W., Zhou, Y., Jiang, Y., Li, S., & Huang, J. (2024) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2024.1424202 · Cited by 9

High-throughput multiplexed serology via the mass-spectrometric analysis of isotopically barcoded beads

Drainas, A. P., McIlwain, D. R., Dallas, A. E., Chu, T. P., Delgado‐González, A., Baron, M., Angulo‐Ibáñez, M., Trejo, A., Bai, Y., Hickey, J. W., et al. (2025) · Nature Biomedical Engineering · doi:10.1038/s41551-025-01349-0 · Cited by 9

Persistence and decay of neutralizing antibody responses elicited by SARS-CoV-2 infection and hybrid immunity in a Canadian cohort

Nouanesengsy, A., Semesi, A., Quách, K. Ư., Ivanochko, D., Byrne, W., Hwang, M. K., Neve, M.-R. L., Leon‐Ponte, M., Litosh, A., Wisener, N., et al. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.01333-24 · Cited by 9

Common cold embecovirus imprinting primes broadly neutralizing antibody responses to SARS-CoV-2 S2

Changrob, S., Yasuhara, A., Park, S., Bangaru, S., Li, L., Troxell, C. A., Halfmann, P., Erickson, S. A., Catanzaro, N., Yuan, M., et al. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20251146 · Cited by 9

Modeling the population effects of escape mutations in SARS-CoV-2 to guide vaccination strategies

Koopman, J. S., Simon, C. P., Getz, W. M., & Salter, R. M. (2021) · Epidemics · doi:10.1016/j.epidem.2021.100484 · Cited by 9

COVID-ONE-hi: The One-Stop Database for COVID-19-Specific Humoral Immunity and Clinical Parameters

Xu, Z., Li, Y., Lei, Q., Huang, L., Lai, D., Guo, S., Jiang, H., Hou, H., Zheng, Y.-X., Wang, X., et al. (2021) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2021.09.006 · Cited by 9

Persistence of Anti-SARS-CoV-2 Antibodies in Long Term Care Residents Over Seven Months After Two COVID-19 Outbreaks

Tanunliong, G., Liu, A. C., Vijh, R., Pidduck, T., Kustra, J., Márquez, A. C., Choi, A., McLennan, M., Hayden, A. S., Kearney, C., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.775420 · Cited by 10

On the caveats of a multiplex test for SARS-CoV-2 to detect seroconversion after infection or vaccination

Fernandes-Siqueira, L. O., Ferreira, F. A. P., Sousa, B. G., Mebus-Antunes, N. C., Neves-Martins, T. C., Almeida, F. C. L., Ferreira, G. C., Salmon, D., Wermelinger, L. S., & Poian, A. T. D. (2022) · Scientific Reports · doi:10.1038/s41598-022-14294-8 · Cited by 9

Distinct Antibody Responses to Endemic Coronaviruses Pre- and Post-SARS-CoV-2 Infection in Kenyan Infants and Mothers

Stoddard, C. I., Sung, K., Ojee, E., Adhiambo, J., Begnel, E. R., Slyker, J. A., Gantt, S. M., Matsen, F. A., IV, Kinuthia, J., Wamalwa, D. C., et al. (2022) · Viruses · doi:10.3390/v14071517 · Cited by 9

Most Japanese individuals are genetically predisposed to recognize an immunogenic protein fragment shared between COVID-19 and common cold coronaviruses

Dijkstra, J. M., Frenette, A. P., & Dixon, B. (2021) · F1000Research · doi:10.12688/f1000research.51479.1 · Cited by 10

Dynamics of SARS-CoV-2-specific antibodies among COVID19 biobank donors in Argentina

Longueira, Y., Polo, M. L., InViV working group, Turk, G., Laufer, N., & Biobanco de Enfermedades Infecciosas Colección COVID19 working group (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e08140 · Cited by 10

Plasmonically Enhanced Ultrasensitive Epitope-Specific Serologic Assay for COVID-19

Wang, Z., Morrissey, J. J., Liu, L., Wang, Y., Zhou, Q., Naik, R. R., & Singamaneni, S. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c03676 · Cited by 9

The Role of Antibodies in the Treatment of SARS-CoV-2 Virus Infection, and Evaluating Their Contribution to Antibody-Dependent Enhancement of Infection

Farouq, M. A. H., Acevedo, R., Ferro, V. A., Mulheran, P. A., & Qaraghuli, M. M. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116078 · Cited by 9

Can machines learn the mutation signatures of SARS-CoV-2 and enable viral-genotype guided predictive prognosis?

Nagpal, S., Pinna, N. K., Pant, N., Singh, R. P., Srivastava, D., & Mande, S. S. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167684 · Cited by 11

The Impact of the Highly Virulent SARS-CoV-2 Gamma Variant on Young Adults in the State of São Paulo: Was It Inevitable?

Spira, B. (2022) · Cureus · doi:10.7759/cureus.26486 · Cited by 9

Association between IgG responses against the nucleocapsid proteins of alphacoronaviruses and COVID-19 severity

Nückel, J., Planatscher, E., Mohr, A., Deichl, K., Mijočević, H., Feuerherd, M., Wolff, L. S., Erber, J., Schneider, J., Quante, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.889836 · Cited by 9

Coronavirus Antibody Responses before COVID-19 Pandemic, Africa and Thailand

Li, Y., Merbah, M., Wollen-Roberts, S. E., Beckman, B., Mdluli, T., Swafford, I., Mayer, S. V., King, J., Corbitt, C., Currier, J. R., et al. (2022) · Emerging infectious diseases · doi:10.3201/eid2811.221041 · Cited by 9

Comparison of the Capacity of Several Machine Learning Tools to Assist Immunofluorescence-Based Detection of Anti-Neutrophil Cytoplasmic Antibodies

Bertin, D., Bongrand, P., & Bardin, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063270 · Cited by 9

In Silico and In Vitro Evaluation of the Molecular Mimicry of the SARS-CoV-2 Spike Protein by Common Short Constituent Sequences (cSCSs) in the Human Proteome: Toward Safer Epitope Design for Vaccine Development

Mizuno, Y., Nakasone, W., Nakamura, M., & Otaki, J. M. (2024) · Vaccines · doi:10.3390/vaccines12050539 · Cited by 9

Associations between HLA-II variation and antibody specificity are predicted by antigen properties

Innocenti, G., Andreu‐Sánchez, S., Hörstke, N. V., ElAbd, H., Barozzi, I., Franke, A., Manczinger, M., & Vogl, T. J. (2025) · Genome Medicine · doi:10.1186/s13073-025-01486-w · Cited by 9

Immune response and potential therapeutic strategies for the SARS-CoV-2 associated with the COVID-19 pandemic

Li, X., Zhang, Y., He, L., Si, J., Qiu, S., He, Y., Wei, J., Wang, Z., Xie, L., Li, Y., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.66369 · Cited by 8

BIPS—A code base for designing and coding of a Phage ImmunoPrecipitation Oligo Library

Leviatan, S., Kalka, I. N., Vogl, T. J., Klompas, S., Weinberger, A., & Segal, E. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010663 · Cited by 8

The repertoire of CSF antiviral antibodies in patients with neuroinflammatory diseases

Enose‐Akahata, Y., Wang, L., Almsned, F. M., Johnson, K. R., Mina, Y., Ohayon, J. M., Wang, X. W., & Jacobson, S. (2023) · Science Advances · doi:10.1126/sciadv.abq6978 · Cited by 8

Primary ChAdOx1 vaccination does not reactivate pre-existing, cross-reactive immunity

Henze, L., Braun, J., Meyer‐Arndt, L., Jürchott, K., Schlotz, M., Michel, J., Grossegesse, M., Mangold, M., Dingeldey, M., Kruse, B., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1056525 · Cited by 7

Selection for immune evasion in SARS-CoV-2 revealed by high-resolution epitope mapping and sequence analysis

N’Guessan, A., Kailasam, S., Mostefai, F., Poujol, R., Grenier, J., Ismailova, N., Contini, P., Palma, R. D., Haber, C., Stadler, V., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107394 · Cited by 9

Faradaic Impedimetric Immunosensor for Label-Free Point-of-Care Detection of COVID-19 Antibodies Using Gold-Interdigitated Electrode Array

Shoute, L. C. T., Charlton, C. L., Kanji, J. N., Babiuk, S., Babiuk, L., & Chen, J. (2023) · Biosensors · doi:10.3390/bios14010006 · Cited by 8

COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 1

Mead, M. N., Seneff, S., Wolfinger, R. D., Rose, J., Denhaerynck, K., Kirsch, S., & McCullough, P. A. (2024) · International Journal of Vaccine Theory Practice and Research · doi:10.56098/fdrasy50 · Cited by 18

Short and long-term immune changes in different severity groups of COVID-19 disease

Maamari, K. A., Busaidi, I. A., Kindi, M. A. A., Zadjali, F., BaAlawi, F., Anesta, W., Amri, K. A., Albalushi, W., Balushi, H. A., Amri, A. A., et al. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.07.026 · Cited by 8

SARS-CoV-2 neutralizing antibody response in vaccinated and non-vaccinated hospital healthcare workers with or without history of infection

Jacot, D., von Rotz, U., Pellaton, C., Blondet, F., Aebischer, O., Perreau, M., Rham, M. D., Pantaleo, G., Marchetti, O., & Greub, G. (2022) · Microbes and Infection · doi:10.1016/j.micinf.2022.105077 · Cited by 7

Kinetics of Immune Subsets in COVID-19 Patients Treated with Corticosteroids

Pappas, A., Chaliasou, A.-L., Panagopoulos, A., Dede, K., Daskalopoulou, S., Moniem, E. H. M. A. A., Polydora, E., Grigoriou, E., Psarra, K., Tsirogianni, A., et al. (2022) · Viruses · doi:10.3390/v15010051 · Cited by 8

SARS-CoV-2 peptides/epitopes for specific and sensitive diagnosis

Jiang, H., Li, Y., & Tao, S. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01001-4 · Cited by 8

Analysis of Stochastic SIRC Model with Cross Immunity Based on Ornstein–Uhlenbeck Process

Ni, Z., Jiang, D., Cao, Z., & Mu, X. (2023) · Qualitative Theory of Dynamical Systems · doi:10.1007/s12346-023-00782-3 · Cited by 8

Comprehensive mapping of SARS-CoV-2 peptide epitopes for development of a highly sensitive serological test for total and neutralizing antibodies

Kumar, G., Sterrett, S., Hall, L., Tabengwa, E. M., Honjo, K., Larimer, M., Davis, R. S., Goepfert, P., & Larimer, B. M. (2022) · Protein Engineering Design and Selection · doi:10.1093/protein/gzab033 · Cited by 7

Neutralizing IFNL3 Autoantibodies in Severe COVID-19 Identified Using Molecular Indexing of Proteins by Self-AssemblyPreprint

Credle, J. J., Gunn, J., Sangkhapreecha, P., Monaco, D. R., Zheng, X. A., Tsai, H.-J., Wilbon, A., Morgenlander, W. R., Dong, Y. W., Jayaraman, S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.02.432977 · Cited by 8

Antibody landscapes of SARS-CoV-2 can reveal novel vaccine and diagnostic targets

Hachim, A., Kavian, N., & Valkenburg, S. A. (2021) · Current Opinion in Virology · doi:10.1016/j.coviro.2021.08.006 · Cited by 7

Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes

Hein, S., Benz, N. I., Eisert, J., Herrlein, M., Oberle, D., Dreher, M., Stingl, J., Hildt, C., & Hildt, E. (2021) · Vaccines · doi:10.3390/vaccines9121419 · Cited by 7

Continued Virus-Specific Antibody-Secreting Cell Production, Avidity Maturation and B Cell Evolution in Patients Hospitalized with COVID-19

Bartlett, M. L., Suwanmanee, S., Akindele, N. P., Ghimire, S., Chan, A. K. P., Guo, C., Gould, S. J., Cox, A. L., & Griffin, D. E. (2022) · Viral Immunology · doi:10.1089/vim.2021.0191 · Cited by 7

Modifiable contributing factors to COVID-19: A comprehensive review

Kostoff, R. N., Briggs, M. B., Kanduc, D., Dewanjee, S., Kandimalla, R. J. L., Shoenfeld, Y., Porter, A. L., & Tsatsakis, A. M. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113511 · Cited by 8

Immunology of SARS-CoV-2 infection and vaccination

Lin, B., Cheng, L., Zhang, J., Yang, M. X., Zhang, Y., Liu, J., & Qin, X. (2023) · Clinica Chimica Acta · doi:10.1016/j.cca.2023.117390 · Cited by 8

Immunogenicity and efficacy of a novel multi-patch SARS-CoV-2/COVID-19 vaccine candidate

Perdiguero, B., Marcos-Villar, L., López‐Bravo, M., Sánchez‐Cordón, P. J., Zamora, C., Valverde, J. R., Sorzano, C. Ó. S., Sin, L., Álvarez, E. A., Ramos, M., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1160065 · Cited by 8

Mapping IgA Epitope and Cross-Reactivity between Severe Acute Respiratory Syndrome-Associated Coronavirus 2 and DENV

De-Simone, S. G., Napoleão-Pêgo, P., Lechuga, G. C., Carvalho, J. P. R. S., Monteiro, M. E. D. S., Morel, C. M., & Provance, D. W. (2023) · Vaccines · doi:10.3390/vaccines11121749 · Cited by 5

Identification of evolutionarily stable functional and immunogenic sites across the SARS-CoV-2 proteome and greater coronavirus family

Wang, C., Konecki, D. M., Marciano, D. C., Govindarajan, H., Williams, A. M., Wastuwidyaningtyas, B., Bourquard, T., Katsonis, P., & Lichtarge, O. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btab406 · Cited by 7

Simple workflow to repurpose SARS-CoV-2 swab/serum samples for the isolation of cost-effective antibody/antigens for proteotyping applications and diagnosis

Tok, K., Moulahoum, H., Ghorbanizamani, F., Harmancı, D., Hanoglu, S. B., Durmus, C., Evran, S., Çiçek, C., Sertoz, R. Y., Arda, B., et al. (2021) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-021-03654-4 · Cited by 7

COVID-19 Antibody Detection and Assay Performance Using Red Cell Agglutination

Srivastava, K., West, K. A., Giorgi, V. D., Holbrook, M. R., Bovin, N. V., Henry, S. M., & Flegel, W. A. (2021) · Microbiology Spectrum · doi:10.1128/spectrum.00830-21 · Cited by 7

Multiplexed Serum Antibody Screening Platform Using Virus Extracts from Endemic Coronaviridae and SARS-CoV-2

Fink, S., Ruoff, F., Stahl, A., Becker, M., Kaiser, P., Traenkle, B., Junker, D., Weise, F., Ruétalo, N., Hörber, S., et al. (2021) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00725 · Cited by 6

Identification of four linear B-cell epitopes on the SARS-CoV-2 spike protein able to elicit neutralizing antibodiesPreprint

Li, L., Zhao, Z., Yang, X., Li, W., Chen, S., Sun, T., Wang, L., He, Y., Liu, G., Han, X., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.13.422550 · Cited by 6

Drug development of an affinity enhanced, broadly neutralizing heavy chain-only antibody that restricts SARS-CoV-2 in rodentsPreprint

Schepens, B., van Schie, L., Nerinckx, W., Roose, K., Breedam, W. V., Fijałkowska, D., Devos, S., Weyts, W., Cae, S. D., Vanmarcke, S., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.08.433449 · Cited by 7

Antiviral Antibody Epitope Selection is a Heritable TraitPreprint

Venkataraman, T., Valencia, C., Mangino, M., Morgenlander, W. R., Clipman, S. J., Liechti, T., Valencia, A., Christofidou, P., Spector, T. D., Roederer, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.25.436790 · Cited by 7

Severe Acute Respiratory Syndrome Coronavirus‐2

Slev, P. R. (2024) · Wiley eBooks · doi:10.1002/9781683674023.ch54 · Cited by 8

Protein–protein and protein–nucleic acid binding site prediction via interpretable hierarchical geometric deep learning

Zhang, S., Han, J., & Liu, J. (2024) · GigaScience · doi:10.1093/gigascience/giae080 · Cited by 5

Enhanced electrochemical detection of SARS-CoV-2 IgG using magnetic nanocomplexes: evaluation of preparation processes and sensor stability

Yildirim, N., Ayni, E., & Kaya, K. (2025) · Journal of Nanoparticle Research · doi:10.1007/s11051-025-06240-2 · Cited by 6

A Multi-level Perspective on the Evolution of Orthologs and Their Functions

Langschied, F., Iruegas, R., Sikora, M., Covino, R., & Ebersberger, I. (2025) · Journal of Molecular Evolution · doi:10.1007/s00239-025-10276-2 · Cited by 5

Comprehensive analysis of SARS-CoV-2 Spike evolution: epitope classification and immune escape prediction

Teruel, N., Crown, M. R., Rajsbaum, R., Bashton, M., & Najmanovich, R. (2025) · Virus Evolution · doi:10.1093/ve/veaf027 · Cited by 7

Targeting heptad repeats and fusion peptide: nanoparticle vaccine elicits mucosal immune response against SARS-CoV-2 variants

Liang, C., Li, R., Pu, Z., Chen, R., Li, Y., Chen, S., Feng, J., Liu, J., Bai, Y., Qin, X., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-025-03582-w · Cited by 6

A stabilized MERS-CoV spike ferritin nanoparticle vaccine elicits robust and protective neutralizing antibody responses

Powell, A. E., Caruso, H., Park, S., Chen, J., O’Rear, J., Ferrer, B., Stieh, D. J., Weiss, A. M., Belnap, D. M., Walker, A. E., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68458-5 · Cited by 6

Self and Nonself Short Constituent Sequences of Amino Acids in the SARS-CoV-2 Proteome for Vaccine Development

Otaki, J. M., Nakasone, W., & Nakamura, M. (2021) · COVID · doi:10.3390/covid1030047 · Cited by 6

A SARS–CoV-2 Spike Receptor Binding Motif Peptide Induces Anti-Spike Antibodies in Mice andIs Recognized by COVID-19 Patients

Pratesi, F., Errante, F., Pacini, L., Peña-Moreno, I. C., Quiceno, S., Carotenuto, A., Balam, S., Konate, D. S., Diakité, M., Arévalo‐Herrera, M., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.879946 · Cited by 5

Exposure to avian coronavirus vaccines is associated with increased levels of SARS‐CoV ‐2‐cross‐reactive antibodies

Ardıçlı, Ö., Çarlı, K. T., Satitsuksanoa, P., Dreher, A., Cusini, A., Hutter, S., Mirer, D., Rückert, B., Jónsdóttir, H. R., Weber, B., et al. (2022) · Allergy · doi:10.1111/all.15441 · Cited by 6

Latent infections, coronavirus disease 2019 and psychiatric disorders: The friend of my enemy

Jahromi, M. A. M., Jahromi, M. S., Taghipour, A., Roustazadeh, A., Matin, S., Mir, H., Badri, M., Bahrami, F., & Abdoli, A. (2022) · Clinical and Translational Discovery · doi:10.1002/ctd2.141 · Cited by 6

Serum Fc-Mediated Monocyte Phagocytosis Activity Is Stable for Several Months after SARS-CoV-2 Asymptomatic and Mildly Symptomatic Infection

Vangeti, S., Periasamy, S., Sun, P., Balinsky, C. A., Mahajan, A. S., Kuzmina, N. A., Schanoski, A. S., Cooper, E. S., Beckett, C. G., Marayag, J., et al. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01837-22 · Cited by 7

Artificial intelligence centric scientific research on COVID-19: an analysis based on scientometrics data

Shukla, A. K., Seth, T., & Muhuri, P. K. (2023) · Multimedia Tools and Applications · doi:10.1007/s11042-023-14642-4 · Cited by 8

The Immunological Profile of SARS-CoV-2 Infection in Children Is Linked to Clinical Severity and Age

Vanetti, C., Stracuzzi, M., Lampasona, V., Fenizia, C., Biasin, M., Saulle, I., Limanaqi, F., Abdelsalam, A., Loretelli, C., Paradiso, L., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076779 · Cited by 6

Establishing SARS-CoV-2 membrane protein-specific antibodies as a valuable serological target via high-content microscopy

Williams, D. M., Hornsby, H. R., Shehata, O. M., Brown, R. L., Gallis, M., Meardon, N., Newman, T., Plowright, M., Zafred, D., Shun-Shion, A. S., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107056 · Cited by 6

Hybrid immunity by two COVID‐19 mRNA vaccinations and one breakthrough infection provides a robust and balanced cellular immune response as basic immunity against severe acute respiratory syndrome coronavirus 2

Almanzar, G., Koosha, K., Vogt, T., Stein, A., Ziegler, L., Asam, C., Weps, M., Schwägerl, V., Richter, L. M., Hepp, N., et al. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29739 · Cited by 6

Drugs Used in the Treatment of Multiple Sclerosis During COVID-19 Pandemic: A Critical Viewpoint

Alborghetti, M., Bellucci, G., Gentile, A., Calderoni, C., Nicoletti, F., Capra, R., Salvetti, M., & Centonze, D. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210330094017 · Cited by 6

Comparable endemic coronavirus nucleoprotein‐specific antibodies in mild and severe Covid‐19 patients

Leach, S., Harandi, A. M., Bergström, T. B., Andersson, L., Nilsson, S., van der Hoek, L., & Gisslén, M. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27038 · Cited by 4

Synthetic proteins for COVID-19 diagnostics

Schein, C. H., Levine, C. B., McLellan, S., Negi, S. S., Braun, W. A., Dreskin, S. C., Anaya, E. S., & Schmidt, J. G. (2021) · Peptides · doi:10.1016/j.peptides.2021.170583 · Cited by 6

ELISA-Based Analysis Reveals an Anti-SARS-CoV-2 Protein Immune Response Profile Associated with Disease Severity

Herrscher, C., Eymieux, S., Gaborit, C., Blasco, H., Marlet, J., Stéfic, K., Roingeard, P., Grammatico‐Guillon, L., & Hourioux, C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11020405 · Cited by 6

Preclinical Establishment of a Divalent Vaccine against SARS-CoV-2

Hevesi, Z., Gerges, D., Kapps, S., Freire, R., Schmidt, S., Pollak, D. D., Schmetterer, K. G., Frey, T., Lang, R., Winnicki, W., et al. (2022) · Vaccines · doi:10.3390/vaccines10040516 · Cited by 6

Dynamics of Neutralizing Antibodies and Binding Antibodies to Domains of SARS-CoV-2 Spike Protein in COVID-19 Survivors

Phakaratsakul, S., Manopwisedjaroen, S., Boonarkart, C., Kupatawintu, P., Chaiwanichsiri, D., Roytrakul, T., Auewarakul, P., & Thitithanyanont, A. (2022) · Viral Immunology · doi:10.1089/vim.2022.0059 · Cited by 6

Immune profiling of SARS-CoV-2 epitopes in asymptomatic and symptomatic pediatric and adult patients

Tornesello, A. L., Botti, C., Micillo, A., Labonia, F., Arpino, S., Isgrò, M. A., Meola, S., Russo, L., Cavalcanti, E., Sale, S., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03963-5 · Cited by 6

Immunity Induced by Inactivated SARS-CoV-2 Vaccine: Breadth, Durability, Potency, and Specificity in a Healthcare Worker Cohort

Chen, Y., Hu, C., Wang, Z., Su, J., Wang, S., Li, B., Liu, X., Yuan, Z., Li, D., Wang, H., et al. (2023) · Pathogens · doi:10.3390/pathogens12101254 · Cited by 4

Mapping the SARS-CoV-2 Epitope Landscape and Uncovering the Origins of Immunodominant Public Epitopes

Shrock, E. L. (2023) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)

ELISA-Based Analysis Reveals an Anti-SARS-CoV-2 Protein Immune Response Profile Associated with Disease Severity

Herrscher, C., Eymieux, S., Gaborit, C., Blasco, H., Marlet, J., Stéfic, K., Roingeard, P., Grammatico‐Guillon, L., & Hourioux, C. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11020405 · Cited by 6

Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity

Amrun, S. N., Lee, C. Y., Lee, B. T. K., Fong, S., Young, B. E., Chee, R. S., Yeo, N. K., Torres‐Ruesta, A., Carissimo, G., Poh, C. M., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102911 · Cited by 142

SARS-CoV-2 Proteome-Wide Analysis Revealed Significant Epitope Signatures in COVID-19 Patients

Schwarz, T., Heiß, K., Mahendran, Y., Casilag, F., Kurth, F., Sander, L. E., Wendtner, C., Hoechstetter, M. A., Müller, M. A., Sekul, R., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.629185 · Cited by 45

Binding signatures and cross-reactivity in the SARS-CoV-2 immune response

Stoddard, C. I., Galloway, J., Chu, H., Shipley, M. M., Sung, K. Y., Itell, H. L., Wolf, C. R., Logue, J. K., Magedson, A., Garrett, M. E., et al. (2021) · Topics in antiviral medicine